Advertisement

Topics

Biohaven's CGPR antagonist #migraine treatment beats placebo in Phase 3 trial http://bit.ly/2LP6HEA  #pharma #neurosciencepic.twitter.com/CvoZh8VcqB

05:34 EDT 11 Jul 2019 | Pharmafile

Biohaven's CGPR antagonist treatment beats placebo in Phase 3 trial http://bit.ly/2LP6HEA 

Original Article: Biohaven's CGPR antagonist #migraine treatment beats placebo in Phase 3 trial http://bit.ly/2LP6HEA  #pharma #neurosciencepic.twitter.com/CvoZh8VcqB

NEXT ARTICLE

More From BioPortfolio on "Biohaven's CGPR antagonist #migraine treatment beats placebo in Phase 3 trial http://bit.ly/2LP6HEA  #pharma #neurosciencepic.twitter.com/CvoZh8VcqB"

Advertisement
Quick Search
Advertisement
Advertisement